| Flavonoids against the SARS-CoV-2 induced inflammatory storm A Liskova, M Samec, L Koklesova, SM Samuel, K Zhai, RK Al-Ishaq, ... Biomedicine & Pharmacotherapy 138, 111430, 2021 | 132 | 2021 |
| Flavonoids against the Warburg phenotype—Concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism M Samec, A Liskova, L Koklesova, SM Samuel, K Zhai, C Buhrmann, ... Epma Journal 11, 377-398, 2020 | 98* | 2020 |
| Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles A Liskova, M Samec, L Koklesova, A Brockmueller, K Zhai, B Abdellatif, ... Epma Journal 12 (2), 155-176, 2021 | 83 | 2021 |
| Calcium entry through TRPV1: a potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells K Zhai, A Liskova, P Kubatka, D Büsselberg International Journal of Molecular Sciences 21 (11), 4177, 2020 | 79 | 2020 |
| Flavonoids targeting HIF-1: Implications on cancer metabolism M Samec, A Liskova, L Koklesova, S Mersakova, J Strnadel, K Kajo, ... Cancers 13 (1), 130, 2021 | 66 | 2021 |
| Resveratrol’s anti-cancer effects through the modulation of tumor glucose metabolism A Brockmueller, S Sameri, A Liskova, K Zhai, E Varghese, SM Samuel, ... Cancers 13 (2), 188, 2021 | 54 | 2021 |
| Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways P Kubatka, A Mazurakova, M Samec, L Koklesova, K Zhai, R Al-Ishaq, ... Epma Journal, 1-29, 2021 | 51* | 2021 |
| Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine L Koklesova, M Samec, A Liskova, K Zhai, D Büsselberg, FA Giordano, ... EPMA Journal 12, 27-40, 2021 | 48 | 2021 |
| Curcumin’s beneficial effects on neuroblastoma: mechanisms, challenges, and potential solutions K Zhai, A Brockmüller, P Kubatka, M Shakibaei, D Büsselberg Biomolecules 10 (11), 1469, 2020 | 44 | 2020 |
| Carotenoids in cancer metastasis—Status quo and outlook L Koklesova, A Liskova, M Samec, K Zhai, M Abotaleb, M Ashrafizadeh, ... Biomolecules 10 (12), 1653, 2020 | 37 | 2020 |
| Flavonoids synergistically enhance the anti-glioblastoma effects of chemotherapeutic drugs K Zhai, A Mazurakova, L Koklesova, P Kubatka, D Büsselberg Biomolecules 11 (12), 1841, 2021 | 34 | 2021 |
| Natural compounds in glioblastoma therapy: Preclinical insights, mechanistic pathways, and outlook K Zhai, M Siddiqui, B Abdellatif, A Liskova, P Kubatka, D Büsselberg Cancers 13 (10), 2317, 2021 | 30 | 2021 |
| Protective effects of flavonoids against mitochondriopathies and associated pathologies: focus on the predictive approach and personalized prevention L Koklesova, A Liskova, M Samec, K Zhai, RK Al-Ishaq, O Bugos, ... International Journal of Molecular Sciences 22 (16), 8649, 2021 | 24 | 2021 |
| Virtual reality therapy for depression and mood in long-term care facilities K Zhai, A Dilawar, MS Yousef, S Holroyd, H El-Hammali, M Abdelmonem Geriatrics 6 (2), 58, 2021 | 22 | 2021 |
| The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer E Kudela, A Liskova, M Samec, L Koklesova, V Holubekova, T Rokos, ... EPMA Journal 12 (2), 199-220, 2021 | 20 | 2021 |
| Metabolic anti-cancer effects of melatonin: clinically relevant prospects M Samec, A Liskova, L Koklesova, K Zhai, E Varghese, SM Samuel, ... Cancers 13 (12), 3018, 2021 | 19 | 2021 |
| Flavonoids alleviate peripheral neuropathy induced by anticancer drugs M Siddiqui, B Abdellatif, K Zhai, A Liskova, P Kubatka, D Büsselberg Cancers 13 (7), 1576, 2021 | 15 | 2021 |
| Deep brain stimulation beyond the clinic: navigating the future of Parkinson’s and Alzheimer’s disease therapy DKL Senevirathne, A Mahboob, K Zhai, P Paul, A Kammen, DJ Lee, ... Cells 12 (11), 1478, 2023 | 11 | 2023 |
| Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks A Liskova, L Koklesova, M Samec, B Abdellatif, K Zhai, M Siddiqui, ... EPMA Journal 12 (3), 325-347, 2021 | 11 | 2021 |
| Optimizing clinical workflow using precision medicine and advanced data analytics K Zhai, MS Yousef, S Mohammed, NI Al-Dewik, MW Qoronfleh Processes 11 (3), 939, 2023 | 10 | 2023 |
Peter KubatkaProfessor, Comenius University in BratislavaVerified email at uniba.sk
